Vandenbranden M[au] - Search Results

Year	Number of Results
1981	3
1982	2
1983	1
1984	2
1985	3
1988	2
1989	4
1990	3
1991	2
1992	2
1993	5
1994	4
1995	2
1996	5
1997	3
1998	6
1999	3
2000	3
2001	1
2002	2
2003	5
2004	3
2005	3
2006	2
2007	2
2008	6
2009	5
2010	2
2011	1
2012	4
2013	1
2014	2
2022	0

1

Cationic lipids activate intracellular signaling pathways.

Lonez C, Vandenbranden M, Ruysschaert JM. Lonez C, et al. Among authors: vandenbranden m. Adv Drug Deliv Rev. 2012 Dec;64(15):1749-58. doi: 10.1016/j.addr.2012.05.009. Epub 2012 May 23. Adv Drug Deliv Rev. 2012. PMID: 22634161 Review.

2

The human drug metabolizing cytochromes P450.

Wrighton SA, VandenBranden M, Ring BJ. Wrighton SA, et al. Among authors: vandenbranden m. J Pharmacokinet Biopharm. 1996 Oct;24(5):461-73. doi: 10.1007/BF02353474. J Pharmacokinet Biopharm. 1996. PMID: 9131485 Review.

3

Cationic lipids activate cellular cascades. Which receptors are involved?

Lonez C, Lensink MF, Vandenbranden M, Ruysschaert JM. Lonez C, et al. Among authors: vandenbranden m. Biochim Biophys Acta. 2009 Jun;1790(6):425-30. doi: 10.1016/j.bbagen.2009.02.015. Epub 2009 Mar 6. Biochim Biophys Acta. 2009. PMID: 19269309 Review.

4

Cationic liposomal lipids: from gene carriers to cell signaling.

Lonez C, Vandenbranden M, Ruysschaert JM. Lonez C, et al. Among authors: vandenbranden m. Prog Lipid Res. 2008 Sep;47(5):340-7. doi: 10.1016/j.plipres.2008.03.002. Epub 2008 Apr 1. Prog Lipid Res. 2008. PMID: 18424270 Review.

5

Immunoglobulin-lipid interaction. A model membrane study.

Vandenbranden M, Kayser G, Banerjee S, Ruysschaert JM. Vandenbranden M, et al. Biochim Biophys Acta. 1982 Feb 23;685(2):177-81. doi: 10.1016/0005-2736(82)90095-5. Biochim Biophys Acta. 1982. PMID: 7059599

6

In vitro methods for assessing human hepatic drug metabolism: their use in drug development.

Wrighton SA, Vandenbranden M, Stevens JC, Shipley LA, Ring BJ, Rettie AE, Cashman JR. Wrighton SA, et al. Among authors: vandenbranden m. Drug Metab Rev. 1993;25(4):453-84. doi: 10.3109/03602539308993982. Drug Metab Rev. 1993. PMID: 8313838 Review. No abstract available.

7

The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies.

Wrighton SA, Ring BJ, VandenBranden M. Wrighton SA, et al. Among authors: vandenbranden m. Toxicol Pathol. 1995 Mar-Apr;23(2):199-208. doi: 10.1177/019262339502300214. Toxicol Pathol. 1995. PMID: 7569675 Review.

8

DiC14-amidine confers new anti-inflammatory properties to phospholipids.

Lonez C, Legat A, Vandenbranden M, Ruysschaert JM. Lonez C, et al. Among authors: vandenbranden m. Cell Mol Life Sci. 2008 Feb;65(4):620-30. doi: 10.1007/s00018-007-7520-1. Cell Mol Life Sci. 2008. PMID: 18097635

9

Lipid mixing between lipoplexes and plasma lipoproteins is a major barrier for intravenous transfection mediated by cationic lipids.

Tandia BM, Lonez C, Vandenbranden M, Ruysschaert JM, Elouahabi A. Tandia BM, et al. Among authors: vandenbranden m. J Biol Chem. 2005 Apr 1;280(13):12255-61. doi: 10.1074/jbc.M414517200. Epub 2005 Jan 20. J Biol Chem. 2005. PMID: 15661732 Free article.

10

Fusogenic activity of cationic lipids and lipid shape distribution.

Lonez C, Lensink MF, Kleiren E, Vanderwinden JM, Ruysschaert JM, Vandenbranden M. Lonez C, et al. Among authors: vandenbranden m. Cell Mol Life Sci. 2010 Feb;67(3):483-94. doi: 10.1007/s00018-009-0197-x. Epub 2009 Nov 19. Cell Mol Life Sci. 2010. PMID: 19924382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results